Latest Articles

Publication Date
DIAGNOSIS AND LAPAROSCOPIC MANAGEMENT OF INTRAHEPATIC ENDOMETRIOMA.

Published: Feb. 14, 2025, midnight
Bladder Endometriosis: Diagnostic, Therapy, and Outcome of a Single-Center Experience.

Background/Objectives: Endometriosis is a benign condition affecting up to 10% of women at reproductive age. The urinary tract is affected in 0.3-12.0% of women with endometriosis and in 19.0-53.0% of …

Published: Feb. 14, 2025, midnight
Alteration of Serum Gal-3 Levels in Endometrium-Related Reproductive Disorders.

Endometriosis, a benign, chronic gynecological disorder characterized by the presence of endometrial-like tissue outside the uterine cavity, affects 15% of women of reproductive age. Galectins, a family of beta-galactoside-binding proteins, …

Published: Feb. 14, 2025, midnight
Endometriosis and adenomyosis research priorities in India and Sri Lanka: a call for regional collaboration.

Endometriosis and adenomyosis are major gynaecological conditions affecting women of reproductive age-group, particularly in low- and middle-income countries. This Health Policy outlined research priorities for India and Sri Lanka, derived …

Published: Feb. 14, 2025, midnight
France grants Ziwig Endotest fast-track reimbursement - BioWorld Online

France grants Ziwig Endotest fast-track reimbursement BioWorld Online

Published: Feb. 13, 2025, 10:50 p.m.
Dr Wagar on the Role of Adjuvant Immunotherapy in Endometrial Cancer - OncLive

Dr Wagar on the Role of Adjuvant Immunotherapy in Endometrial Cancer OncLive

Published: Feb. 13, 2025, 8:12 p.m.
Early Diagnosis Changes Endometriosis Care: Conference 2025 - Endometriosis Foundation of America - The Blossom

Early Diagnosis Changes Endometriosis Care: Conference 2025 Endometriosis Foundation of America - The Blossom

Published: Feb. 13, 2025, 6:57 p.m.
Gesynta Pharma Receives $27 M For Endometriosis Novel Therapy Drug - Forbes

Gesynta Pharma Receives $27 M For Endometriosis Novel Therapy Drug Forbes

Published: Feb. 13, 2025, 5:04 p.m.
Gesynta Pharma Receives $27 Million For Endometriosis Novel Therapy Drug - Forbes

Gesynta Pharma Receives $27 Million For Endometriosis Novel Therapy Drug Forbes

Published: Feb. 13, 2025, 5:04 p.m.
S2 Episode 2: Endometrial Cancer Disparities: Access to Care and Trials - Medscape

S2 Episode 2: Endometrial Cancer Disparities: Access to Care and Trials Medscape

Published: Feb. 13, 2025, 2:52 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!